discussion outline
DESCRIPTION
Discussion Outline. Cells of the Immune System. Innate Immunity. Receptors on T and B Cells Are Specific for Each Antigen. Innate and Adaptive Immune Systems. Antigen Presentation. Adaptive Immunity. Function of the Immune System. Tumor Escape Mechanisms. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/1.jpg)
![Page 2: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/2.jpg)
![Page 3: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/3.jpg)
![Page 4: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/4.jpg)
Discussion Outline
![Page 5: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/5.jpg)
Cells of the Immune System
![Page 6: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/6.jpg)
Innate Immunity
![Page 7: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/7.jpg)
Receptors on T and B Cells Are Specific for Each Antigen
![Page 8: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/8.jpg)
Innate and Adaptive Immune Systems
![Page 9: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/9.jpg)
Antigen Presentation
![Page 10: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/10.jpg)
Adaptive Immunity
![Page 11: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/11.jpg)
Function of the Immune System
![Page 12: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/12.jpg)
Tumor Escape Mechanisms
![Page 13: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/13.jpg)
Risk for Malignancies Is Higher in Immunosuppressed Patients With Organ Transplants Compared With in Healthy
Individuals*
![Page 14: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/14.jpg)
Cancer and Immunoediting
![Page 15: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/15.jpg)
Antigen Presentation and T-Cell Priming
![Page 16: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/16.jpg)
Reasons for Failed Vaccine Studies
![Page 17: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/17.jpg)
Tumor Antigens
![Page 18: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/18.jpg)
Dual Role of the Immune System in Cancer
![Page 19: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/19.jpg)
Chimeric Antigen-Receptor T Cells for Lymphoma
![Page 20: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/20.jpg)
Multiple Costimulatory and Inhibitory Interactions Regulate T-Cell Responses
![Page 21: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/21.jpg)
CTLA-4: Negatively Modulates the Immune Response
![Page 22: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/22.jpg)
Phase 3 Trial of Ipilimumab in Melanoma
![Page 23: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/23.jpg)
Progression-Free Survival in Patients Receiving Ipilimumab for
Lung Cancer
![Page 24: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/24.jpg)
Immune Checkpoints Regulate the Immune System
![Page 25: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/25.jpg)
Phase 1 Study: Activity of Nivolumab
![Page 26: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/26.jpg)
Targeted Agents Against Immune Checkpoint Pathways
![Page 27: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/27.jpg)
Antibodies to Tumor-Expressing Antigens
![Page 28: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/28.jpg)
Measuring Response With Immune Therapies
![Page 29: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/29.jpg)
Future Objectives
![Page 30: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/30.jpg)
Nivolumab + Ipilimumab in Patients With Advanced Melanoma
![Page 31: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/31.jpg)
Combination Studies of Checkpoint Inhibitors
![Page 32: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/32.jpg)
Conclusions
![Page 33: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/33.jpg)
Abbreviations
![Page 34: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/34.jpg)
Abbreviations (cont)
![Page 35: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/35.jpg)
Abbreviations (cont)
![Page 36: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/36.jpg)
References
![Page 37: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/37.jpg)
References (cont)
![Page 38: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/38.jpg)
References (cont)
![Page 39: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/39.jpg)
References (cont)
![Page 40: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/40.jpg)
References (cont)
![Page 41: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/41.jpg)
References (cont)
![Page 42: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/42.jpg)
References (cont)
![Page 43: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/43.jpg)
References (cont)
![Page 44: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/44.jpg)
References (cont)
![Page 45: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/45.jpg)
References (cont)
![Page 46: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/46.jpg)
References (cont)
![Page 47: Discussion Outline](https://reader030.vdocument.in/reader030/viewer/2022032606/56812ca8550346895d91517d/html5/thumbnails/47.jpg)
References (cont)